mRNA-encoded, constitutively active STINGV155M is a potent genetic adjuvant of antigen-specific CD8+ T cell response
Authors:
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 29 (7) , 2227-2238
Abstract
No abstract availableKeywords
Funding Information
- Moderna (US20180311343A1)
This publication has 70 references indexed in Scilit:
- IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS SignalingPLOS Pathogens, 2013
- TRAM Is Involved in IL-18 Signaling and Functions as a Sorting Adaptor for MyD88PLOS ONE, 2012
- Direct activation of antigen-presenting cells is required for CD8+T-cell priming and tumor vaccinationProceedings of the National Academy of Sciences, 2011
- STING is a direct innate immune sensor of cyclic di-GMPNature, 2011
- Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LNucleic Acids Research, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- Contribution of Ser386 and Ser396 to Activation of Interferon Regulatory Factor 3Journal of Molecular Biology, 2008
- Cancer Immunotherapy Using Irradiated Tumor Cells Secreting Heat Shock Protein 70Cancer Research, 2007